← Back to headlines
Merck's Investment Boosts Funding for Vaginal Drug Delivery Research
Merck has significantly impacted the funding landscape for vaginal drug delivery, addressing a previous lack of investment in the area.
20 Apr, 11:00 — 20 Apr, 11:00
Sources
Showing 1 of 1 sources



